HOPMAN MARK (Chief Commercial Officer) sold 2.1% of their position (2.92K shares) of BETA BIONICS, INC. on the open market
Open‑market sale worth $88.3K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 2 sales
Filed: 3/16/2026ACC: 0002048497-26-000004
Officer· Chief Commercial Officer
Since Mar 2026
-2.92K
Net shares
Net seller
$88.3K
Total sold
2
Open market trades
0B · 2S
2
Total transactions
2.92K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
−856.00
Price / share
$29.34
Trade value
$25.11K
% of position
0.6%
12/2/2025
139.13K→138.28K
Common Stock
Direct
Shares
−2.06K
Price / share
$30.66
Trade value
$63.19K
% of position
1.5%
12/4/2025
138.28K→136.22K
Total
Net shares
−2.92K
Net value
-$88.30K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 12/2/2025 | S · Sale | −856.00 | $29.34 | $25.11K | 0.6% | 139.13K | 138.28K |
| Common Stock Direct | 12/4/2025 | S · Sale | −2.06K | $30.66 | $63.19K | 1.5% | 138.28K | 136.22K |
| Total | −2.92K | -$88.30K | ||||||
Derivative Transactions0
No derivative transactions reported